SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-13-044185
Filing Date
2013-08-09
Accepted
2013-08-09 09:30:55
Documents
8
Period of Report
2013-08-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v352365_8k.htm 8-K 23793
2 EXHIBIT 4.1 v352365_ex4-1.htm EX-4.1 82564
3 EXHIBIT 4.2 v352365_ex4-2.htm EX-4.2 83160
4 EXHIBIT 5.1 v352365_ex5-1.htm EX-5.1 10487
5 EXHIBIT 10.1 v352365_ex10-1.htm EX-10.1 206686
6 EXHIBIT 10.2 v352365_ex10-2.htm EX-10.2 60721
7 EXHIBIT 99.1 v352365_ex99-1.htm EX-99.1 11926
8 GRAPHIC image_001.jpg GRAPHIC 4606
  Complete submission text file 0001144204-13-044185.txt   487033
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35737 | Film No.: 131024705
SIC: 2834 Pharmaceutical Preparations